Generic placeholder image

Current Nanoscience

Editor-in-Chief

ISSN (Print): 1573-4137
ISSN (Online): 1875-6786

Mini-Review Article

Advances on Highly Selective and Non-invasive Screening of Cancer Biomarkers using Surface Enhanced Raman Scattering with Nanoparticles

Author(s): Keerthana Madhivanan and Ashok Kumar Sundramoorthy*

Volume 22, Issue 1, 2026

Published on: 13 January, 2025

Page: [1 - 9] Pages: 9

DOI: 10.2174/0115734137351673241121072348

Price: $65

Abstract

Cancer has long been the leading cause of death in many countries. This complex category of diseases is characterized by the uncontrolled growth and spread of abnormal cells. To reduce the cancer mortality rate, early detection of the disease is essential. As a result, extensive research is directed towards the early identification of the cancer disease by developing novel cancer cell detection technologies. One such novel technology is Surface Enhanced Raman Scattering (SERS). This technique is highly sensitive because of the highly enhanced SERS signals due to metal nanoparticles, which allow the detection of ultra-low concentration (femto-molar) of several important cancer biomarkers. Moreover, metal nanoparticle-based SERS is found to be more sensitive and can be used for the detection of cancer cells or biomarkers over a longer period. The SERS is also useful for multiple biomarker detection. Compared to other fluorescence bands, Raman bands are narrower, which allows for the individual and simultaneous detection of multiple biomarkers. In this context, we have outlined the latest advancements in SERS for the effective detection of cancer biomarkers. Additionally, we discuss the current challenges and future potential of SERS in cancer cell detection.

Keywords: Surface enhanced raman scattering, cancer biomarkers, Ag and Au nanoparticles, real-time analysis, cancer cell detection technologies, ultra-low concentration (femto-molar).

Next »
Graphical Abstract
[1]
Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin., 2014, 64(1), 9-29.
[http://dx.doi.org/10.3322/caac.21208] [PMID: 24399786]
[2]
Worldwide cancer data 2022. Available from: https://www.wcrf.org/cancer-trends/worldwide-cancer-data/(accessedon 4-11-2024).
[3]
Aardra, B.S.; Anitha, P.; Smiline Girija, A.S.; Paramasivam, A.; Vijayashree Priyadharsini, J. Analysis of differentially expressed genes in dysplastic oral keratinocyte cell line and their role in the development of HNSCC. J. Stomatol. Oral Maxillofac. Surg., 2024, 125(4), 101928.
[http://dx.doi.org/10.1016/j.jormas.2024.101928] [PMID: 38815724]
[4]
Arumugam, P. Targeting oncogenic protein arginine methyltransferase 5 as a treatment strategy for head and neck cancer. Oral Oncol. Rep., 2024, 10, 100334.
[http://dx.doi.org/10.1016/j.oor.2024.100334]
[5]
Anitha, P.; Paramasivam, A.; Priyadharsini, V.J. Evolution of CRISPR technology and its implications in oral cancer diagnosis. Oral Oncol. Rep., 2024, 10, 100403.
[http://dx.doi.org/10.1016/j.oor.2024.100403]
[6]
Sridharan, G.; Ganapathy, D.; Ramadoss, R.; Atchudan, R.; Arya, S.; Sundramoorthy, A.K. Biosensors for rapid and accurate determination of oral cancer. Oral Oncol. Rep., 2023, 5, 100021.
[http://dx.doi.org/10.1016/j.oor.2023.100021]
[7]
Balu, S.; Sundramoorthy, A.K. Label-free immunosensors for the ultrasensitive detection of cancer biomarkers. Oral Oncol. Rep., 2024, 10, 100273.
[http://dx.doi.org/10.1016/j.oor.2024.100273]
[8]
Sundramoorthy, A.K. Selection of best biomarker for the early detection of oral squamous cell carcinoma. Oral Oncol. Rep., 2024, 9, 100197.
[http://dx.doi.org/10.1016/j.oor.2024.100197]
[9]
Sridharan, G.; Atchudan, R.; Magesh, V.; Arya, S.; Ganapathy, D.; Nallaswamy, D.; Sundramoorthy, A.K. Advanced electrocatalytic materials based biosensors for cancer cell detection – A review. Electroanalysis, 2023, 35(9), e202300093.
[http://dx.doi.org/10.1002/elan.202300093]
[10]
Madhivanan, K.; Atchudan, R.; Arya, S.; Sundramoorthy, A.K. Utilization of nanomaterials functionalized bio-field-effect transistors for detection of cancer biomarkers. Oral Oncol. Rep., 2024, 10, 100363.
[http://dx.doi.org/10.1016/j.oor.2024.100363]
[11]
Tian, M.; Wu, R.; Xiang, C.; Niu, G.; Guan, W. Recent advances in fluorescent probes for cancer biomarker detection. Molecules, 2024, 29(5), 1168.
[http://dx.doi.org/10.3390/molecules29051168] [PMID: 38474680]
[12]
Wang, H.; Wu, T.; Li, M.; Tao, Y. Recent advances in nanomaterials for colorimetric cancer detection. J. Mater. Chem. B Mater. Biol. Med., 2021, 9(4), 921-938.
[http://dx.doi.org/10.1039/D0TB02163F] [PMID: 33367450]
[13]
Madhivanan, K.; Ganapathy, D.; Sundramoorthy, A.K. Molecularly imprinted polymers based sensors for identification of various cancer biomarkers. Oral Oncol. Rep., 2024, 9, 100211.
[http://dx.doi.org/10.1016/j.oor.2024.100211]
[14]
Law, W.C.; Yong, K.T.; Baev, A.; Prasad, P.N. Sensitivity improved surface plasmon resonance biosensor for cancer biomarker detection based on plasmonic enhancement. ACS Nano, 2011, 5(6), 4858-4864.
[http://dx.doi.org/10.1021/nn2009485] [PMID: 21510685]
[15]
Sundramoorthy, A.K.; Atchudan, R.; Arya, S. Utilization of Raman spectroscopy in biochemical fingerprint analysis for oral cancer screening and diagnosis. Oral Oncol., 2022, 135, 106192.
[http://dx.doi.org/10.1016/j.oraloncology.2022.106192] [PMID: 36270203]
[16]
Issaq, H.J.; Veenstra, T.D. The role of electrophoresis in disease biomarker discovery. Electrophoresis, 2007, 28(12), 1980-1988.
[http://dx.doi.org/10.1002/elps.200600834] [PMID: 17503404]
[17]
Wu, L.; Qu, X. Cancer biomarker detection: Recent achievements and challenges. Chem. Soc. Rev., 2015, 44(10), 2963-2997.
[http://dx.doi.org/10.1039/C4CS00370E] [PMID: 25739971]
[18]
Qian, J.; Zhao, L.; Huang, Y.; Zhao, C.; Liu, H.; Liu, X.; Cheng, Z.; Yu, F. A microdroplet SERS-RCA biosensor with enhanced specificity and reproducibility for profiling dual miRNAs in idiopathic pulmonary fibrosis diagnosis and monitoring. Chem. Eng. J., 2024, 482, 149012.
[http://dx.doi.org/10.1016/j.cej.2024.149012]
[19]
Chakraborty, A.; Ghosh, A.; Barui, A. Advances in surface‐enhanced Raman spectroscopy for cancer diagnosis and staging. J. Raman Spectrosc., 2020, 51(1), 7-36.
[http://dx.doi.org/10.1002/jrs.5726]
[20]
Nargis, H.F.; Nawaz, H.; Bhatti, H.N.; Jilani, K.; Saleem, M. Comparison of surface enhanced Raman spectroscopy and Raman spectroscopy for the detection of breast cancer based on serum samples. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2021, 246, 119034.
[http://dx.doi.org/10.1016/j.saa.2020.119034] [PMID: 33049470]
[21]
Sridharan, G.; Murugan, R.V.; Atchudan, R.; Arya, S.; Sundramoorthy, A.K. Electrochemical detection of dopamine using green synthesized gold nanoparticles from Strobilanthes kunthiana’s leaf extract. Nano Life, 2024, 2024, S1793984424500156.
[http://dx.doi.org/10.1142/S1793984424500156]
[22]
Koo, K.M.; Wee, E.J.H.; Mainwaring, P.N.; Wang, Y.; Trau, M. Toward precision medicine: A cancer molecular subtyping nano‐strategy for RNA biomarkers in tumor and urine. Small, 2016, 12(45), 6233-6242.
[http://dx.doi.org/10.1002/smll.201602161] [PMID: 27717152]
[23]
Chang, H.; Kang, H.; Ko, E.; Jun, B.H.; Lee, H.Y.; Lee, Y.S.; Jeong, D.H. PSA detection with femtomolar sensitivity and a broad dynamic range using SERS nanoprobes and an area-scanning method. ACS Sens., 2016, 1(6), 645-649.
[http://dx.doi.org/10.1021/acssensors.6b00053]
[24]
Wang, J.; Koo, K.M.; Wee, E.J.H.; Wang, Y.; Trau, M. A nanoplasmonic label-free surface-enhanced Raman scattering strategy for non-invasive cancer genetic subtyping in patient samples. Nanoscale, 2017, 9(10), 3496-3503.
[http://dx.doi.org/10.1039/C6NR09928A] [PMID: 28240336]
[25]
Li, X.; Zhang, Y.; Xue, B.; Kong, X.; Liu, X.; Tu, L.; Chang, Y.; Zhang, H. A SERS nano-tag-based fiber-optic strategy for in situ immunoassay in unprocessed whole blood. Biosens. Bioelectron., 2017, 92, 517-522.
[http://dx.doi.org/10.1016/j.bios.2016.10.070] [PMID: 27836611]
[26]
Yang, K.; Hu, Y.; Dong, N.; Zhu, G.; Zhu, T.; Jiang, N. A novel SERS-based magnetic aptasensor for prostate specific antigen assay with high sensitivity. Biosens. Bioelectron., 2017, 94, 286-291.
[http://dx.doi.org/10.1016/j.bios.2017.02.048] [PMID: 28292735]
[27]
Yang, L.; Gao, M.X.; Zhan, L.; Gong, M.; Zhen, S.J.; Huang, C.Z. An enzyme-induced Au@Ag core–shell nanostructure used for an ultrasensitive surface-enhanced Raman scattering immunoassay of cancer biomarkers. Nanoscale, 2017, 9(7), 2640-2645.
[http://dx.doi.org/10.1039/C6NR07979B] [PMID: 28155925]
[28]
Granger, J.H.; Granger, M.C.; Firpo, M.A.; Mulvihill, S.J.; Porter, M.D. Toward development of a surface-enhanced Raman scattering (SERS)-based cancer diagnostic immunoassay panel. Analyst (Lond.), 2013, 138(2), 410-416.
[http://dx.doi.org/10.1039/C2AN36128K] [PMID: 23150876]
[29]
Ma, H.; Sun, X.; Chen, L.; Han, X.X.; Zhao, B.; Lu, H.; He, C. Antibody-free discrimination of protein biomarkers in human serum based on surface-enhanced Raman spectroscopy. Anal. Chem., 2018, 90(21), 12342-12346.
[http://dx.doi.org/10.1021/acs.analchem.8b03701] [PMID: 30338981]
[30]
Lu, Z.; Huang, Y.; Cao, M. Electrochemical surface-enhanced Raman spectroscopy for structure analysis of 1, 4-benzenedithiol assembled on gold nanoparticles. Int. J. Electrochem. Sci., 2022, 17(9), 220970.
[http://dx.doi.org/10.20964/2022.09.64]
[31]
Li, M.; Cushing, S.K.; Zhang, J.; Suri, S.; Evans, R.; Petros, W.P.; Gibson, L.F.; Ma, D.; Liu, Y.; Wu, N. Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma. ACS Nano, 2013, 7(6), 4967-4976.
[http://dx.doi.org/10.1021/nn4018284] [PMID: 23659430]
[32]
Fleischmann, M.; Hendra, P.J.; McQuillan, A.J. Raman spectra of pyridine adsorbed at a silver electrode. Chem. Phys. Lett., 1974, 26(2), 163-166.
[http://dx.doi.org/10.1016/0009-2614(74)85388-1]
[33]
Boujday, S.; Chapelle, M.; Srajer, J.; Knoll, W. Enhanced vibrational spectroscopies as tools for small molecule biosensing. Sensors (Basel), 2015, 15(9), 21239-21264.
[http://dx.doi.org/10.3390/s150921239] [PMID: 26343666]
[34]
Subash, R.; Sridharan, G.; Nallaswamy, D.; Atchudan, R.; Arya, S.; Sundramoorthy, A.K. Electrochemical detection of nitrofurantoin using green synthesized silver-doped palladium nanocluster-modified sensor. Nanosci. Nanotechnol. Asia, 2024, 14(3), e250324228304.
[http://dx.doi.org/10.2174/0122106812282033240320102203]
[35]
Ito, T.; Okazaki, S. Pushing the limits of lithography. Nature, 2000, 406(6799), 1027-1031.
[http://dx.doi.org/10.1038/35023233] [PMID: 10984061]
[36]
Chen, Y. Nanofabrication by electron beam lithography and its applications: A review. Microelectron. Eng., 2015, 135, 57-72.
[http://dx.doi.org/10.1016/j.mee.2015.02.042]
[37]
Colson, P.; Henrist, C.; Cloots, R. Nanosphere lithography: A powerful method for the controlled manufacturing of nanomaterials. J. Nanomater., 2013, 2013(1), 948510.
[http://dx.doi.org/10.1155/2013/948510]
[38]
Guo, L.J. Recent progress in nanoimprint technology and its applications. J. Phys. D Appl. Phys., 2004, 37(11), R123-R141.
[http://dx.doi.org/10.1088/0022-3727/37/11/R01]
[39]
Smith, C.J.; Osborn, A.M. Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology. FEMS Microbiol. Ecol., 2009, 67(1), 6-20.
[http://dx.doi.org/10.1111/j.1574-6941.2008.00629.x] [PMID: 19120456]
[40]
Teymouri, M.; Mollazadeh, S.; Mortazavi, H. Naderi Ghale-noie, Z.; Keyvani, V.; Aghababaei, F.; Hamblin, M.R.; Abbaszadeh-Goudarzi, G.; Pourghadamyari, H.; Hashemian, S.M.R.; Mirzaei, H. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol. Res. Pract., 2021, 221, 153443.
[http://dx.doi.org/10.1016/j.prp.2021.153443] [PMID: 33930607]
[41]
Arya, S.K.; Estrela, P. Recent advances in enhancement strategies for electrochemical ELISA-based immunoassays for cancer biomarker detection. Sensors (Basel), 2018, 18(7), 2010.
[http://dx.doi.org/10.3390/s18072010] [PMID: 29932161]
[42]
Nimse, S.B.; Sonawane, M.D.; Song, K.S.; Kim, T. Biomarker detection technologies and future directions. Analyst (Lond.), 2016, 141(3), 740-755.
[http://dx.doi.org/10.1039/C5AN01790D] [PMID: 26583164]
[43]
Cheng, Z.; Choi, N.; Wang, R.; Lee, S.; Moon, K.C.; Yoon, S.Y.; Chen, L.; Choo, J. Simultaneous detection of dual prostate specific antigens using surface-enhanced Raman scattering-based immunoassay for accurate diagnosis of prostate cancer. ACS Nano, 2017, 11(5), 4926-4933.
[http://dx.doi.org/10.1021/acsnano.7b01536] [PMID: 28441008]
[44]
Schlücker, S. SERS microscopy: Nanoparticle probes and biomedical applications. ChemPhysChem, 2009, 10(9-10), 1344-1354.
[http://dx.doi.org/10.1002/cphc.200900119] [PMID: 19565576]
[45]
Xu, K.; Zhou, R.; Takei, K.; Hong, M. Toward flexible surface-enhanced Raman scattering (SERS) sensors for point-of-care diagnostics. Adv. Sci. (Weinh.), 2019, 6(16), 1900925.
[http://dx.doi.org/10.1002/advs.201900925] [PMID: 31453071]
[46]
Connolly, J.M.; Davies, K.; Kazakeviciute, A.; Wheatley, A.M.; Dockery, P.; Keogh, I.; Olivo, M. Non-invasive and label-free detection of oral squamous cell carcinoma using saliva surface-enhanced Raman spectroscopy and multivariate analysis. Nanomedicine, 2016, 12(6), 1593-1601.
[http://dx.doi.org/10.1016/j.nano.2016.02.021] [PMID: 27015768]
[47]
Tan, Y.; Yan, B.; Xue, L.; Li, Y.; Luo, X.; Ji, P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis., 2017, 16(1), 73.
[http://dx.doi.org/10.1186/s12944-017-0465-y] [PMID: 28388900]
[48]
Clarke, O.J.R.; Goodall, B.L.; Hui, H.P.; Vats, N.; Brosseau, C.L. Development of a SERS-based rapid vertical flow assay for point-of-care diagnostics. Anal. Chem., 2017, 89(3), 1405-1410.
[http://dx.doi.org/10.1021/acs.analchem.6b04710] [PMID: 28208248]
[49]
Dixon, K.; Bonon, R.; Ivander, F.; Ale Ebrahim, S.; Namdar, K.; Shayegannia, M.; Khalvati, F.; Kherani, N.P.; Zavodni, A.; Matsuura, N. Using machine learning and silver nanoparticle-based surface-enhanced Raman spectroscopy for classification of cardiovascular disease biomarkers. ACS Appl. Nano Mater., 2023, 6(17), 15385-15396.
[http://dx.doi.org/10.1021/acsanm.3c01442] [PMID: 37706067]
[50]
Choi, N.; Dang, H.; Das, A.; Sim, M.S.; Chung, I.Y.; Choo, J. SERS biosensors for ultrasensitive detection of multiple biomarkers expressed in cancer cells. Biosens. Bioelectron., 2020, 164, 112326.
[http://dx.doi.org/10.1016/j.bios.2020.112326] [PMID: 32553352]
[51]
Balu, S.; Atchudan, R.; Arya, S.; Sundramoorthy, A.K. The role of gold nanostructures in the development of detection devices for oral squamous cell carcinoma. Oral Oncol. Rep., 2024, 9, 100146.
[http://dx.doi.org/10.1016/j.oor.2023.100146]
[52]
Qian, X.; Peng, X.H.; Ansari, D.O.; Yin-Goen, Q.; Chen, G.Z.; Shin, D.M.; Yang, L.; Young, A.N.; Wang, M.D.; Nie, S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol., 2008, 26(1), 83-90.
[http://dx.doi.org/10.1038/nbt1377] [PMID: 18157119]
[53]
Lussier, F.; Thibault, V.; Charron, B.; Wallace, G.Q.; Masson, J.F. Deep learning and artificial intelligence methods for Raman and surface-enhanced Raman scattering. Trends Analyt. Chem., 2020, 124, 115796.
[http://dx.doi.org/10.1016/j.trac.2019.115796]
[54]
Guo, S.; Dong, S. Metal nanomaterial-based self-assembly: Development, electrochemical sensing and SERS applications. J. Mater. Chem., 2011, 21(42), 16704.
[http://dx.doi.org/10.1039/c1jm11382h]
[55]
Wahab, M.R.A.; Palaniyandi, T.; Ravi, M.; Viswanathan, S.; Baskar, G.; Surendran, H.; Gangadharan, S.G.D.; Rajendran, B.K. Biomarkers and biosensors for early cancer diagnosis, monitoring and prognosis. Pathol. Res. Pract., 2023, 250, 154812.
[http://dx.doi.org/10.1016/j.prp.2023.154812]
[56]
Ghosh, S.; Rajendran, R.L.; Mahajan, A.A.; Chowdhury, A.; Bera, A.; Guha, S.; Chakraborty, K.; Chowdhury, R.; Paul, A.; Jha, S.; Dey, A. Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell Int., 2024, 24, 278.
[http://dx.doi.org/10.1186/s12935-024-03464-5]
[57]
Aalami, A.H.; Shahriari, A.; Mazaheri, M.; Aalami, F.; Sahebkar, A. Advancing gastrointestinal cancer diagnostics: A systematic review and meta-analysis of circulating microRNA-1246 as a non-invasive biomarker. Biomarkers, 2024, 29, 233-243.
[http://dx.doi.org/10.1080/1354750X.2024.2350714]

Rights & Permissions Print Cite
© 2026 Bentham Science Publishers | Privacy Policy